fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic linked to higher risk

Some providers offer tirzepatide sublingual dosing , which has its own absorption characteristics

These treatments work by mimicking certain hormones in your body that target areas in the brain which regulate appetite and calorie intake

But as these medications become the standard of care for obesity, an important question is emerging from the orthopedic and musculoskeletal literature: what happens to bone density and lean muscle mass during rapid, pharmacologically driven weight loss

a baseline recording was taken for 1 minute before addition of 100 nM exendin-4 and further imaging for 10 minutes

Disclaimer: Pricing is based on a low-dose 2.2 mg plan